Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report

Lupus. 2011 Dec;20(14):1551-3. doi: 10.1177/0961203311411353. Epub 2011 Aug 9.

Abstract

Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of systemic lupus erythematosus (SLE). Cases complicated with DAH often have active SLE with multi-organ involvement, especially lupus nephritis. We describe a rare case of DAH as the first presenting manifestation of SLE in the absence of lupus nephritis. Remission was induced by IV methylprednisolone, IV cyclophosphamide, and plasmapheresis. Further cycles of cyclophosphamide were prevented by recurrent infections. Maintenance of remission was successfully achieved with oral mycophenolate mofetil 1 g twice daily, with a good control of SLE and without further DAH episodes.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Hemoptysis / drug therapy
  • Hemoptysis / etiology*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Mycophenolic Acid